BORTEZOMIB OR THALIDOMIDE INCORPORATED INTO AUTOLOGOUS STEM CELL TRANSPLANTATION VERSUS NOVEL AGENT-BASED TREATMENTS FOR ELDERLY PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA: A CASE-MATCH COMPARISON
EHA Library, Paola Tacchetti, 53825
INTRACELLULAR CALCIUM DEPOSITS AND STORE OPERATED CALCIUM ENTRY IN CD34+ CELLS FROM PATIENTS WITH MYELOFIBROSIS CARRYING A CALR MUTATION
EHA Library, Vittorio Rosti, 53834
VEGF-INDUCED CA2+ SIGNALS ARE DERANGED IN ENDOTHELIAL PROGENITOR CELLS FROM PATIENTS WITH MYELOFIBROSIS CARRYING JAK2 MUTATIONS
EHA Library, Francesco Moccia, 53835
LOW RATE OF CALR MUTATIONS IN REFRACTORY ANAEMIA WITH RING SIDEROBLASTS AND MARKED THROMBOCYTOSIS
EHA Library, Francois Girodon, 53837
GATA1 IS OVEREXPRESSED IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA AND IT IS NORMALIZED BY ANAGRELIDE TREATMENT.
EHA Library, Ciro Rinaldi, 53838
IMPORTANCE OF CALR MUTATIONS IN THE DIAGNOSIS OF PRIMARY MYELOFIBROSIS.
EHA Library, Lurdes Zamora Plana, 53839
MOUSE LEUKEMIC TRANSFORMATION IN PMF XENOGRAFT MODEL REVEALS PARACRINE REGULATION IN DISEASE PROGRESSION
EHA Library, Ioanna Triviai, 53841
CYTOGENETIC INVESTIGATION OF G-CSF-STIMULATED PERIPHERAL BLOOD IN PATIENTS WITH PRIMARY MYELOFIBROSIS
EHA Library, Rostyslav Lozynskyy, 53842
CHARACTERIZATION OF MPL-MUTATED MYELOID NEOPLASMS: A REVIEW OF 224 MPL+ CASES
EHA Library, Keming Lin, 53843
DEREGULATION OF MICRORNA146B-1 IS ASSOCIATED WITH MYELOFIBROSIS IN MYELOPROLIFERATIVE NEOPLASMS
EHA Library, Jung Sook Ha, 53844
HIGH THROUGHPUT SCREENING ON PERIPHERAL BLOOD CD34 CELLS WITH A FLOW CYTOMETRY AUTOMATED PLATFORM (EXVITECH), TO IDENTIFY SENSITIVITY TO RUXOLITINIB IN MYELOFIBROSIS PATIENTS
EHA Library, Alicia Arenas, 53845
HEMATOPOIETIC PROGENITOR CELLS EXPRESSING VE-CADHERIN ARE DETECTABLE IN THE SPLEEN OF PATIENTS WITH MYELOFIBROSIS AND ARE IN CLOSE CONTACT WITH MICROVESSELS
EHA Library, Vittorio Rosti, 53846
EVALUATION OF THE ASSOCIATION BETWEEN JAK2 46/1 HAPLOTYPE AND MYELOPROLIFERATIVE NEOPLASMS
EHA Library, Jung Sook Ha, 53847
OUTCOME OF JAK2/MPL/CALR TRIPLE NEGATIVE PATIENTS WITH MYELOFIBROSIS AFTER ALLOGENEIC STEM CELL TRANSPLANTATION
EHA Library, Victoria Panagiota, 53850
CLINICAL CHARACTERISTICS IN MYELOPROLIFERATIVE NEOPLASM WITH CALRETICULIN MUTATIONS
EHA Library, Tunde Krahling, 53854
JAK2 V617F ALLELE BURDEN AND VASCULAR COMPLICATION OCCURRENCE RISK IN PATIENTS WITH PHILADELPHIA-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS
EHA Library, Martyna Borowczyk, 53855
RUXOLITINIB PLUS PANOBINOSTAT IN PATIENTS WITH PRIMARY MYELOFIBROSIS, POST–POLYCYTHEMIA VERA MYELOFIBROSIS OR POST–ESSENTIAL THROMBOCYTHEMIA MYELOFIBROSIS: A PHASE 1B DOSE-FINDING STUDY
EHA Library, Alessandro M. Vannucchi, 53856
UTILITY OF BONE MARROW HISTOLOGY AND IMMUNOHISTOCHEMISTRY IN THE DIAGNOSTIC WORK-UP OF EOSINOPHILIA OF UNKNOWN SIGNIFICANCE
EHA Library, Georgia Metzgeroth, 53857
INFLUENCE OF IL-28B AND IL-6 GENETIC POLYMORPHISM ON IFN-ALFA TREATMENT OUTCOME IN PATIENTS WITH POLYCYTHEMIA VERA AND ESSENTIAL TROMBOCYTHEMIA
EHA Library, Marie Lindgren, 53858
DYNAMICS OF CALR MUTANT ALLELE BURDEN IN ESSENTIAL THROMBOCYTHEMIA PATIENTS
EHA Library, Beatriz Bellosillo, 53859
RESPONSE TO RUXOLITINIB IN PATIENTS WITH INTERMEDIATE-1, INTERMEDIATE-2 AND HIGH-RISK MYELOFIBROSIS: RESULTS OF THE UK ROBUST TRIAL
EHA Library, Adam Mead, 53860
TREATMENT OF PATIENTS WITH PHILADELPHIA-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS WITH PEGYLATED INTERFERON ALPHA-2A: A PROSPECTIVE MONOCENTER COHORT STUDY.
EHA Library, Valerio De Stefano, 53861
SPECIFIC DETECTION OF CALR-MUTATED MYELOPROLIFERATIVE NEOPLASMS BY IMMUNOSTAINING
EHA Library, Giada Rotunno, 53862
MICROARRAY ANALYSIS OF CHROMOSOME 11Q IN A GROUP OF AGGRESSIVE LYMPHOMA: THE PARTIAL DUPLICATION OF 11Q AS A CYTOGENETIC MARKER OF SUBSET OF THE GREY ZONE BETWEEN BURKITT'S (BL) AND DIFFUSE LARGE B-C
EHA Library, Beata Grygalewicz, 53864
CLONAL EVOLUTION IN BURKITT LYMPHOMA/LEUKEMIA
EHA Library, Sietse Aukema, 53867
HIGH EXPRESSION OF MIRNA-199A_1 AND MIRNA-497_1 IS ASSOCIATED WITH BETTER OVERALL SURVIVAL IN AGGRESSIVE NON-HODGKIN´S LYMPHOMA
EHA Library, Katharina Troppan, 53871
LOSS OF BCL2L12 PROTEIN EXPRESSION PREDICTS RELAPSE IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH RITUXIMAB PLUS CONVENTIONAL CHEMOTHERAPY (CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, AN
EHA Library, Sotirios Papageorgiou, 53872
NR4A3-MEDIATED APOPTOSIS SUPPRESSES LYMPHOMAGENESIS IN A XENOGRAFT MOUSE MODEL
EHA Library, Alexander Deutsch, 53873
CONSTITUTIVE ACTIVATION OF THE DNA DAMAGE RESPONSE PATHWAY IS A NOVEL THERAPEUTIC TARGET IN DIFFUSE LARGE B-CELL LYMPHOMA.
EHA Library, Enrico Derenzini, 53875
KINOME REPROGRAMMING IN DLBCL BY THE BTK-SPECIFIC INHIBITOR ONO-4059 HIGHLIGHTS SYNERGISTIC COMBINATIONS FOR CLINICAL APPLICATION
EHA Library, Ryohei Kozaki, 53877
PRECLINICAL EVALUATION OF A NOVEL, HIGHLY POTENT AND SELECTIVE PI3K-DELTA INHIBITOR, CPL-302-201, FOR THE TREATMENT OF HEMATOLOGIC MALIGNANCIES
EHA Library, Aleksandra Stanczak, 53878
Computerized image analysis of the Ki-67 proliferation index for risk stratification of patients with mantle cell lymphoma
EHA Library, Yngvild Nuvin Blaker, 53881
Flow cytometric analysis of SOX11: a new diagnostic method for distingusing B-CLL from MCL
EHA Library, Martin Lord, 53882
AMC AND ALC IN FOLLICULAR LYMPHOMA: PROGNOSTIC ROLE IN PFS
EHA Library, Stefano Sacchi, 53883
BRIEF RITUXIMAB, BENDAMUSTINE, MITOXANTRONE (R-BM) INDUCTION PLUS RITUXIMAB CONSOLIDATION IN ELDERLY DE NOVO ADVANCED STAGE FOLLICULAR LYMPHOMA: FINAL RESULTS OF A STUDY BY FONDAZIONE ITALIANA LINFOMI
EHA Library, Carola Boccomini, 53884
BENDAMUSTINE IS NOT ASSOCIATED WITH AN INCREASE IN INFECTIONS – SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
EHA Library, Anat Gafter-Gvili, 53885
EXPRESSION OF CD200 AND CD148 IN LEUKEMIC B-CELL CHRONIC LYMPHOPROLIFERATIVE DISORDERS
EHA Library, Lei Fan, 53886
ABEXINOSTAT (S78454) A HISTONE DEACETYLASE INHIBITOR, IN PATIENTS WITH REFRACTORY OR RELAPSED HODGKIN'S LYMPHOMA, NON-HODGKIN LYMPHOMA AND CHRONIC LYMPHOCYTIC LEUKAEMIA: PRELIMINARY PHASE II RESULTS.
EHA Library, broussais-guillaumot florence, 53887
HIGH-DOSE CLARITHROMYCIN IS A FEASIBLE AND ACTIVE MONOTHERAPY FOR PATIENTS WITH RELAPSED/REFRACTORY EXTRANODAL MARGINAL ZONE LYMPHOMA [EMZL]: RESULTS FROM THE 'HD-K' PHASE II TRIAL
EHA Library, Andres Jose Maria Ferreri, 53888
EPIDEMIOLOGY OF NON-HODGKIN LYMPHOMA IN THE US: DISTRIBUTION BY SUBTYPES, DEMOGRAPHICS, AND TRENDS FROM 1998-2011
EHA Library, Ronald Go, 53889
CLINICAL COMPARABILITY OF BCD-020 TO INNOVATOR RITUXIMAB IN PATIENTS WITH INDOLENT NON-HODGKIN'S LYMPHOMA
EHA Library, Ekaterina Chernyaeva, 53894
OCCURRENCE OF CHRONIC THERAPY-RELATED HYPOGAMMAGLOBULINAEMIA IN INDOLENT NON HODGKIN LYMPHOMA: SINGLE CENTRE EXPERIENCE.
EHA Library, Alessandro Pulsoni, 53895
PERIPHERAL BLOOD LYMPHOCYTE/MONOCYTE RATIO (LMR) >2 IS ASSOCIATED WITH BETTER OUTCOME IN FOLLICULAR LYMPHOMA (FL): A SINGLE CENTRE EXPERIENCE
EHA Library, ANGELO BELOTTI, 53896
THE SECOND PRIMARY CANCER RISK AFTER NON HODGKIN LYMPHOMA IS NOT INFLUENCED BY THE SUBTYPE: DATA FROM THE FRENCH CANCER REGISTRIES NETWORK (FRANCIM).
EHA Library, Cédric Rossi, 53899
HEAVY/LIGHT CHAIN CHARACTERISTICS OF PATIENTS WITH INDOLENT AND AGGRESSIVE LYMPHOMAS
EHA Library, Oscar Berlanga, 53900
R-CHOP THERAPY ALONE FOR LIMITED-STAGE FOLLICULAR LYMPHOMA: A RETROSPECTIVE STUDY
EHA Library, Naoto Tomita, 53901
PROGRESSION-FREE SURVIVAL AS A SURROGATE ENDPOINT FOR OVERALL SURVIVAL IN RELAPSED-REFRACTORY MANTLE CELL LYMPHOMA
EHA Library, Matthew Wasserman, 53902
Frequency of surveillance computed tomography in non-Hodgkin lymphoma and risk of secondary primary malignancies
EHA Library, Sheng-Hsuan Chien, 53903
MYD88 (L265P) MUTATION IS AN INDEPENDENT PROGNOSTIC FACTOR IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA
EHA Library, Conchi Fernández Rodríguez, 53905
THE ADDITION OF RITUXIMAB TO CODOX-M/IVAC CHEMOTHERAPY IN THE TREATMENT OF BURKITT LYMPHOMA IS SAFE AND IS ASSOCIATED WITH INCREASED EFFICACY IN THE HIV POSITIVE POPULATION
EHA Library, Ferras Alwan, 53906
APOPTOTIC POLYMORPHISMS ARE INVOLVED IN AGGRESSIVENESS AND PROGNOSIS OF DIFFUSE LARGE B-CELL LYMPHOMA
EHA Library, Angelo Brito, 53909
BRENTUXIMAB VEDOTIN IN REFRACTORY OR RELAPSED PERIPHERAL T-CELL LYMPHOMA: THE FRENCH NAME PATIENT PROGRAM EXPERIENCE IN 65 PATIENTS
EHA Library, Lamarque Mathilde, 53911
THE ORAL SELECTIVE INHIBITOR OF NUCLEAR EXPORT (SINE) SELINEXOR (KPT-330) ACTIVITY IN DOUBLE HIT DIFFUSE LARGE B CELL LYMPHOMAS (DLBCL) IN PRECLINICAL MODELS & CLINICAL ACTIVITY IN PATIENTS WITH DLBCL
EHA Library, CHRISTINE CHEN, 53912
CLINICAL IMPACT OF INCLUSION AND TIMING OF RADIOTHERAPY IN THE TREATMENT OF LIMITED-STAGE NK/T-CELL LYMPHOMA
EHA Library, Bohee Lee, 53914
EFFICALY OF M-NHL-BFM-90 TREATMENT PROTOCOL FOR PATIENTS WITH PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA
EHA Library, Anna Misyurina, 53915
BISPECIFIC T-CELL ENGAGER (BiTE®) ANTIBODY BLINATUMOMAB IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL): AN OPEN-LABEL PHASE 2 STUDY
EHA Library, Andreas Viardot, 53916
NON PEGILATED LIPOSOMAL DOXORUBICIN IS SAFE AND EFFECTIVE AS PART OF R-COMP IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA AND MODERATE/SEVERE HEART DISEASE. RESULTS OF HEART01 TRIAL BY THE FONDAZIONE ITALIANA LINFOMI
EHA Library, Michele Spina, 53917
HIGH DOSES OF ANTIMETABOLITES FOLLOWED BY HIGH-DOSE SEQUENTIAL CHEMOIMMUNOTHERAPY AND AUTOLOGOUS STEM CELL TRANSPLANT IN SYSTEMIC B-CELL LYMPHOMAS WITH CNS INVOLVEMENT: A MULTICENTER PHASE II TRIAL
EHA Library, Andres Jose Maria Ferreri, 53918
R-ESHAP-LENALIDOMIDE AS SALVAGE THERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA CANDIDATES TO STEM-CELL TRANSPLANTATION: UPDATED RESULTS OF A PHASE IB GELTAMO STUDY
EHA Library, Alejandro Martín, 53919
NCCN-INTERNATIONAL PROGNOSTIC INDEX (NCCN-IPI) IS A POTENTIAL PROGNOSTIC MODEL IN PATIENTS WITH PERIPHERAL T-CELL LYMPHOMA
EHA Library, Pengpeng Xu, 53920
RITUXIMAB-CHOP PLUS INTRATHECAL METHOTREXATE AND CONTRALATERAL TESTIS IRRADIATION IN UNTREATED PRIMARY TESTICULAR DIFFUSE LARGE B-CELL LYMPHOMA: LONG-TERM RESULTS OF THE IELSG-10 TRIAL
EHA Library, Annalisa Chiappella, 53921
THE NOVEL ROLE OF BONE MARROW INVOLVEMENT DETECTED BY BOTH STAGING AND INTERIM FDG PET-CT IN DIFFUSE LARGE B-CELL LYMPHOMAS
EHA Library, Wei Xu, 53922
MIR-155 IS ASSOCIATED WITH THE LEUKEMOGENIC POTENTIAL OF CLASS IV G-CSFR IN CD34+ PROGENITOR CELLS
EHA Library, Constanca Ferreira de Figueiredo, 53923
THE ROLE OF EPITHELIAL TO MESENCHYMAL TRANSITION IN THE REMODELING OF LUNG INJURY INDUCED BY ACUTE GRAFT-VERSUS-HOST DISEASE
EHA Library, Qifa Liu, 53924
RECIPIENT BATF3 DEPENDENT DENDRITIC CELLS SUPPRESS ACUTE GRAFT-VERSUS-HOST DISEASE AFTER EXPERIMENTAL ALLOGENEIC BONE MARROW TRANSPLANTATION
EHA Library, Markus Radsak, 53928
DISRUPTED TOLL-LIKE RECEPTOR SIGNALING OF INTESTINAL EPITHELIUM IN INTESTINAL GRAFT-VERSUS-HOST DISEASE
EHA Library, Qifa Liu, 53929
RECONSTITUTION OF GPI-ANCHOR-NEGATIVE NK CELL POPULATIONS AFTER ALLOGENEIC STEM CELL TRANSPLANTATION FOLLOWING ALEMTUZUMAB-BASED CONDITIONING
EHA Library, Aline Naomi Lay, 53931
ACTIVATED MONOCYTE-PHAGOCYTES PROBABLY INITIATE THE ONSET OF PRE-ENGRAFTMENT SYNDROME (PES) FOLLOWING UMBILICAL CORD BLOOD TRANSPLANTATION
EHA Library, Jian Wang, 53933
INFLUENCE OF HLA-G POLYMORPHISM ON VIRAL REACTIVATION AND OVERALL SURVIVAL AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION
EHA Library, Elisabetta Metafuni, 53934
MYELOID DERIVED SUPPRESSOR CELLS ARE MOBILIZED BY G-CSF IN MICE AND MEN
EHA Library, Katrin Wetzko, 53935
GRANULOCYTE COLONY-STIMULATING FACTOR MOBILIZATION AFFECTS THE EXPRESSION OF TH1/TH2 CHEMOKINES AND THEIR RECEPTORS
EHA Library, Qifa Liu, 53936
GRANULOCYTE COLONY-STIMULATING FACTOR MOBILIZATION AFFECTS THE EXPRESSION OF REGULATORY GAMMA DELTA T CELLS
EHA Library, Qifa Liu, 53937
EFFECT OF UPREGULATED TLR2 EXPRESSION FROM G-CSF-MOBILIZED DONOR GRAFT ON ACUTE GRAFT-VERSUS-HOST DISEASE IN MICE
EHA Library, Young-Don Joo, 53940
ALDEHYDE DEHYDROGENASE-BRIGHT CELLS CORRELATED WITH THE COLONY FORMING UNIT-GRANULOCYTE/MACROPHAGE ASSAY OF THAWED CORD BLOOD UNITS
EHA Library, Hye Ryun Lee, 53941
A MACHINE LEARNING BASED MODEL FOR PREDICTION OF NRM 100 DAYS POST ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (ALLO-HSCT). A EUROPEAN REGISTRY DATA MINING STUDY.
EHA Library, Roni Shouval, 53942
CONTRASTING EFFECT OF MISSING SELF MODEL AND ACTIVATING DONOR KIR GENES WITH RELEVANT HLA LIGAND IN RECIPIENTS ON PREVENTING RELAPSE AFTER T-CELL-REPLETE HAPLOIDENTICAL TRANSPLANTATION IN CML
EHA Library, Xiangyu Zhao, 53943
IMPACT OF SMOKING ON THE NON-RELAPSE MORTALITY, THE OVERALL SURVIVAL, AND THE INCIDENCE OF SECOND CANCERS AFTER REDUCED INTENSITY ALLOGENEIC STEM CELL TRANSPLANTATION FOR HEMATOLOGIC MALIGNANCIES
EHA Library, Francesco Spina, 53944
A POTENTIAL BENEFIT OF INHIBITORY KIR-MISMATCHED UNMANIPULATED HAPLOIDENTICAL STEM CELL TRANSPLANTATION FOLLOWING TBI-BASED CONDITIONING IN ADULT PATIENTS WITH AML
EHA Library, Seung-Ah Yahng, 53947
HIGH BURDEN OF CD34+/CD38-CELLS PREDICTS WORSE OUTCOME IN ACUTE MYELOID LEUKEMIA (AML) PATIENTS AFTER ALLOGENEIC STEM CELL TRANSPLANTATION (HCT) WITH REDUCED INTENSITY CONDITIONING (RIC)
EHA Library, Madlen Jentzsch, 53948
PROGNOSTIC SIGNIFICANCE OF IDH MUTATIONS IN ACUTE MYELOID LEUKEMIA (AML) PATIENTS UNDERGOING HEMATOPIETIC STEMCELL TRANSPLANTATION (HCT) AFTER REDUCED INTENSITY CONDITIONING (RIC)
EHA Library, Marius Bill, 53949
DECREASE OF INVASIVE FUNGAL DISEASE IN OUR CENTER WITH THE USE OF VORICONAZOLE AS ANTIFUNGAL PROPHYLAXIS IN PATIENTS UNDERGOING ALLOGENEIC STEM CELL TRANSPLANTATION
EHA Library, Carolina Chic Acevedo, 53952
LONG-TERM SURVIVAL IN PATIENTS RECEIVING RHEPO FOLLOWING ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION
EHA Library, Aurélie Jaspers, 53953
PLASMA PROHNPS ARE SPECIFIC EARLY MARKERS OF NEUTROPHIL ENGRAFTMENT IN PATIENTS UNDERGOING HIGH-DOSE CHEMOTHERAPY, AUTOLOGOUS OR ALLOGENEIC STEM CELL TRANSPLANTATION
EHA Library, Andreas Glenthøj, 53955
HIGH-DOSE PREPARATION WITH THIOTEPA/ETOPOSIDE/ARA-C/MELPHALAN (TEAM) VS BEAM FOR AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION (AUTOHSCT) IN LYMPHOMA: A RETROSPECTIVE STUDY FROM THE EBMT
EHA Library, Peter Dreger, 53957
CO-TRANSPLANTATION OF HAPLOIDENTICAL TRANSPLANTATION AND UMBILICAL CORD BLOOD UNIT PROVIDE SIGNIFICANT SURVIVAL BENEFIT FOR PATIENTS WITH LEUKEMIA
EHA Library, Depei Wu, 53958
THE IMPACT OF PRETRANSPLANT IRON CHELATING THERAPY WITH DEFERASIROX ON THE OUTCOME IN PATIENTS WITH SEVERE APASTIC ANEMIA UNDERGOING ALLOGENEIC STEM CELL TRANSPLANTATION
EHA Library, Sung-Eun Lee, 53960
IMPACT OF MONOSOMAL KARYOTYPE ON THE OUTCOMES OF ALLOGENEIC HEMATOPOIETIC TRANSPLANTATION FOR OLDER PATIENTS (>60 YEARS OF AGE) WITH AML/MDS.
EHA Library, Jose Leis, 53961
LACK OF GLUCOCORTICOID-INDUCED LEUCINE ZIPPER (GILZ) RESULTS IN B CELL LYMPHOPROLIFERATIVE DISORDER IN MICE
EHA Library, Oxana Bereshchenko, 53964
A ROLE OF C/EBP-ALPHA IN DEVELOPMENT OF PLASMACYTOID DENDRITIC CELLS IN THE THYMUS
EHA Library, Albert Wölfler, 53968
HISTONE DEACETYLACE INHIBITOR VORINOSTAT REDUCES KIT EXPRESSION IN SYSTEMIC MASTOCYTOSIS
EHA Library, Hani Abdulkadir Ali, 53970
ASSOCIATION OF AN IMPAIRED BONE MARROW VASCULAR MICROENVIRONMENT WITH PRIMARY FAILURE OF PLATELET ENGRAFTMENT AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
EHA Library, Yuan Kong, 53971
REGULATION OF B LYMPHOPOIESIS BY SIGNAL-TRANSDUCING ADAPTOR PROTEIN-2, STAP-2
EHA Library, Michiko Ichii, 53972
IMPACT OF COLD SHOCK PROTEIN YBX1 ON HEMATOPOIETIC STEM CELL DEVELOPMENT AND FUNCTION
EHA Library, Florian Heidel, 53973
IMMUNOMODULATION EFFECTS OF MESENCHYMAL STEM CELLS IN THE TREATMENT OF REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE
EHA Library, Qifa Liu, 53975
MUTATIONAL ANALYSIS OF BONE MARROW MESENCHIMAL STROMAL CELLS IN MYELOID MALIGNANCIES
EHA Library, Emiliano Fabiani, 53977
ADDITION OF PLERIXAFOR TO G-CSF IMPROVES THE GRAFT CONTENT IN SIDE POPULATION (SP) WITH IMMATURE PHENOTYPE IN PATIENTS THAT FAILED TO RESPOND WELL TO G-CSF ALONE.
EHA Library, Bijou Fontanet, 53978
THE IRON CHELATOR DEFERASIROX AFFECTS REDOX SIGNALING IN HEALTHY HEMATOPOIETIC STEM CELLS
EHA Library, Tiziana Tataranni, 53979
ADMISSION OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES TO INTENSIVE CARE UNITS
EHA Library, Margarida Badior, 54030

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.



{$cookies-google-tag-manager-description}


Save Settings